Why We Sleep: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
Line 62:
💊 '''14 – Hurting and Helping Your Sleep: Pills vs. Therapy.''' A randomized controlled trial in JAMA (Norway, 2004–2005) assigned 46 older adults with chronic insomnia to six weeks of CBT‑I, nightly zopiclone 7.5 mg, or placebo; at six months, the CBT‑I group’s polysomnographic sleep efficiency rose from 81.4% to 90.1% and slow‑wave sleep increased, while the medication group showed no durable advantage over placebo. In 2016 the American College of Physicians made CBT‑I first‑line treatment for chronic insomnia, reflecting results across delivery modes (individual, group, digital). A 2015 Annals meta‑analysis pooling 20 RCTs (1,162 participants) quantified what patients feel: ~19 minutes faster sleep onset, ~26 minutes less wake after sleep onset, and nearly 10 percentage points higher sleep efficiency, with benefits persisting beyond treatment. Drug therapy can help in select cases, but the U.S. FDA added a 2019 boxed warning to zolpidem, zaleplon, and eszopiclone for rare yet serious “complex sleep behaviors” (sleep‑driving, cooking, injury, even death). Pharmacologically induced sleep also changes architecture—often shifting spindles and REM proportions—so sedation may not restore the same next‑day cognition as natural sleep. CBT‑I, by contrast, uses stimulus control and sleep restriction to rebuild a tight association between bed and sleep and to amplify adenosine pressure before lights‑out. The practical takeaway is to start with behaviors and only layer medications briefly, with clear goals and exit plans. Mechanistically, CBT‑I reshapes learned associations and recalibrates the sleep‑wake switch; pills can open the door, but lasting change comes from how you schedule, cue, and value sleep.
🏛️ '''15 – Sleep and Society: What Medicine and Education Are Doing Wrong; What Google and NASA Are Doing Right.''' In the 1990s at NASA Ames, long‑haul pilots were given a 40‑minute in‑seat “controlled rest” window; 93% actually slept, averaging 26 minutes, and those short naps boosted alertness while eliminating microsleeps during descent and landing. Outside the cockpit, companies started testing similar ideas—Google even installed EnergyPod nap chairs with privacy visors and built‑in audio in its offices to make 15‑ to 20‑minute naps normal. Schools show what timing can do at scale: a University of Minnesota multi‑district study following more than 9,000 students found that when high schools shifted start times later (for example, from 7:35 to 8:55), car crashes among 16‑ to 18‑year‑olds fell by about 70% and grades and attendance improved. Yet the CDC reported that in the 2011–2012 school year fewer than one in five U.S. middle and high schools started at 8:30 a.m. or later, with an average start time of 8:03 a.m., so biology still loses to the bell schedule. Medicine shows the same pattern: a New England Journal of Medicine trial found that interns working frequent ≥24‑hour shifts made substantially more serious medical errors, and a companion study tied each extended shift to a 9.1% rise in monthly car‑crash risk. The backbone is simple: when systems respect circadian timing and sleep pressure, performance improves and harm drops. The mechanism is alignment—light, timing, and recovery are inputs you can design, and small structural changes (later starts, strategic naps, shorter overnight shifts) create compounding gains. ''Why, then, do we overvalue employees that undervalue sleep?''
🔭 '''16 – A New Vision for Sleep in the Twenty-First Century.''' The chapter opens with a concrete model for change: at Aetna, a company with nearly fifty thousand employees, workers could earn bonuses for meeting sleep targets verified by wearable data, a signal that rest is a performance metric, not a perk. Public health agencies point the same way—pediatricians have urged 8:30 a.m. or later school starts since 2014, and national surveillance shows most districts still miss that mark—so the blueprint stretches from bedrooms to boardrooms to school boards. Safety‑critical sectors already have templates: NASA’s controlled‑rest protocols show that short, planned naps (about 26 minutes of actual sleep) restore alertness without destabilizing operations. The chapter then widens to infrastructure—smarter evening light, cooler bedrooms, and “bedtime alarms” to cue wind‑downs—because the easiest wins come from environments that make good sleep automatic. It’s a systems play: individuals set consistent sleep windows; organizations add nap spaces, flexible shifts, and sleep‑positive incentives; education delays first bell; policy aligns daylight, transport, and healthcare scheduling with circadian biology. Core idea: treat sleep like infrastructure—measure it, design for it, and reward it—so incentives and environments pull in the same direction. Mechanism: reduce circadian misalignment and increase homeostatic pressure at the right times; when timing and pressure line up, people fall asleep faster, sleep deeper, and perform better. ''I believe it is time for us to reclaim our right to a full night of sleep, without embarrassment or the damaging stigma of laziness.''
== Background & reception ==
| |||